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Abstract
Clostridium difﬁcile is a critically important cause of disease in humans, particularly in hospitalized individuals. Three major factors have
raised concern about the potential for this pathogen to be a cause of foodborne disease: the increasing recognition of community-asso-
ciated C. difﬁcile infection, recent studies identifying C. difﬁcile in food animals and food, and similarities in C. difﬁcile isolates from animals,
food and humans. It is clear that C. difﬁcile can be commonly found in food animals and food in many regions, and that strains important
in human infections, such as ribotype 027/NAP1/toxinotype III and ribotype 078/toxinotype V, are often present. However, it is cur-
rently unclear whether ingestion of contaminated food can result in colonization or infection. Many questions remain unanswered
regarding the role of C. difﬁcile in community-associated diarrhoea: its source when it is a food contaminant, the infective dose, and the
association between ingestion of contaminated food and disease. The signiﬁcant role of this pathogen in human disease and its potential
emergence as an important community-associated pathogen indicate that careful evaluation of different sources of exposure, including
food, is required, but determination of the potential role of food in C. difﬁcile infection may be difﬁcult.
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Introduction
Clostridium difﬁcile is a Gram-positive, anaerobic, spore-form-
ing bacterium that has come to the forefront as an important
human pathogen. It was initially dismissed as a commensal in
healthy infants [1], but was recognized as an important cause
of antimicrobial-associated diarrhoea in the 1970s. It is now
the most commonly diagnosed cause of antimicrobial-associ-
ated and hospital-associated diarrhoea, and the cause of
virtually all cases of pseudomembranous colitis [2].
The normal location for C. difﬁcile is the intestinal tract
of humans and various animal species. The pathophysiology
of C. difﬁcile infection (CDI, formerly referred to as C. difﬁ-
cile-associated diarrhoea) is only partially understood, and
involves overgrowth of toxigenic strains of C. difﬁcile, fol-
lowed by production of toxins and the development of a
range of clinical signs, from mild self-limiting diarrhoea to
life-threatening pseudomembranous colitis, toxic megacolon
and/or intestinal perforation [2,3]. It is assumed that dis-
ruption of the normal protective gastrointestinal microﬂora
is an important factor for C. difﬁcile overgrowth and dis-
ease [4]. Antimicrobial therapy is the most widely
reported risk factor [5,6], but other risk factors have been
identiﬁed [7,8], and an inciting cause is not apparent in all
cases.
The main virulence factors that are currently recognized
are two large clostridial toxins, toxin A (TcdA, an entero-
toxin) and toxin B (TcdB, a cytotoxin) [9]. A third, large,
unrelated toxin, designated C. difﬁcile binary toxin (CDT),
can also be produced by some strains [9–11]. The role of
binary toxin in disease is currently unclear [12,13], but there
is information suggesting that this toxin may be clinically rele-
vant [14]. Most toxigenic strains produce both TcdA and
TcdB. A small percentage of clinically relevant strains pro-
duce TcdB but not TcdA [15]. Previously, the prevalence of
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binary toxin-producing strains was low (<10%) [10,11]; how-
ever, this has increased in recent years, and binary toxin-
producing strains now represent more than 30% of isolates
from humans in some studies [13,16,17].
Typing and Nomenclature
C. difﬁcile typing techniques and nomenclature are not stan-
dardized; various systems are used, which can result in difﬁ-
culties in comparing different studies. PCR ribotyping,
pulsed-ﬁeld gel electrophoresis (PFGE) and toxinotyping are
currently the main typing techniques. Accordingly, strains are
often classiﬁed using a combination of names from different
typing methods. Two types currently receive the greatest
attention. One is termed ribotype 027 or NAP1 (North
American pulsovar 1) according to PFGE. It is a toxino-
type III strain that has genes encoding TcdA, TcdB and CDT.
It also has an 18-bp deletion and upstream mutation in tcdC,
a toxin regulatory gene, which has been associated with
increased production of TcdA and TcdB in vitro [18]. This
strain has been implicated in outbreaks of severe disease
internationally [13,19,20], and is also a common endemic
strain in many regions [16,21,22]. Another potentially impor-
tant strain, particularly in community-associated disease, is
ribotype 078, a toxinotype V strain that corresponds with
NAP7 or NAP8 [23]. Like ribotype 027, this strain possesses
genes encoding TcdA, TcdB and CDT. It also has a deletion
in tcdC, but of 39 bp, and a mutation in a different upstream
region. This strain produces more TcdA and TcdB in vitro
than strains with wild-type tcdC, but less than ribotype 027
[24]. However, it is unclear whether this toxin overproduc-
tion contributes to increased virulence in vivo.
Changing Epidemiology in Humans
There have been two main changes in the epidemiology of
CDI over the past 10 years. The ﬁrst was an increase in the
incidence and severity of hospital-associated CDI, with large
outbreaks, high mortality rates, and poorer response to
treatment, reported internationally [13,19,20,25]. This has
been largely attributed to the emergence and dissemination
of ribotype 027/NAP1 but other factors, such as the increas-
ing use of ﬂuoroquinolones, may also be involved [5,26].
The second apparent change has been the increasing rec-
ognition of community-associated (CA) disease. This includes
disease in young individuals and other people traditionally
considered to be at low risk [27,28], although there is some
debate as to whether this is an emerging problem or
whether it was overlooked in the past. Along with increasing
recognition of CA CDI, an increase in the prevalence of tox-
inotype V strains has been observed, particularly ribo-
type 078: from 3% to 13% in The Netherlands [29], from
3.3% to 11% in France [30], and from <0.02% to 1.3% in the
USA [24]. There are also indications that these strains may
be over-represented in CA CDI [24,29].
C. difﬁcile in Food Animals
Concerns regarding the potential for foodborne transmission
of C. difﬁcile inevitably arose following isolation of C. difﬁcile
from the faeces of food animals (cattle, pigs and chickens) in
various countries (Table 1).
The role of C. difﬁcile in animal disease varies with species,
with a clear role of enteric disease in young piglets [31,32],
and less convincing evidence for calves [33–35]. The major
public health concern, however, involves shedding of C. difﬁ-
cile by clinically normal animals, as that population could con-
stitute a large and inapparent reservoir of this pathogen for
contamination of food, water and the environment.
Although data regarding C. difﬁcile in food animals are
compelling, care must be taken when interpreting currently
available studies. Only a limited number of studies have been
published, and these have typically involved a small number
of geographical regions, with different sampling methods and
culture techniques. These methodological variations preclude
TABLE 1. Prevalence of isolation and ribotype distribution
of Clostridium difﬁcile from food animals and retail meat
Country
Sample
type
Prevalence
(%)
Ribotype 027/
toxinotype
III (%)
Ribotype 078/
toxinotype
V (%)
Canada [34] Calves 15 12 26
USA [33] Calves 25 0 94
Canada [40] Veal calves 49 0/1 65
Slovenia [61] Calves 1.8 0 0
Austria [49] Cows 4.5 0 0
Slovenia [36] Chickens 62 0 0
Austria [49] Chickens 5 0 0
Zimbabwe [62] Chickens 29 NT NT
Slovenia [61] Piglets 52 0 0/77
USA [32] Piglets 79 NT NT
USA [63] Piglets NA 0 83
Austria [49] Pigs 3.3 0 0/50
Canada [37] Piglets 95 0 94
Canada [44] Beef, veal 20 0/67 0
USA [23] Various 42 27 73
Canada [45] Beef, veal 6.1 0/27 0
Canada [46] Pork 1.8 43/57 0
Canada [47] Chicken 15 0 96
Canada [48] Pork
Beef
12
12
7.1/14
7.1
71
86
NT, typing was not performed; NA, not applicable, as the study was an evalua-
tion of previously collected isolates.
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the comparison of prevalence data from different studies.
Furthermore, it is apparent that there is signiﬁcant variation
in C. difﬁcile colonization among different age groups in
calves, piglets and chickens, with C. difﬁcile rates decreasing
substantially over time [36, 38–40].
For example, a longitudinal study of pigs in one swine
operation noted 50% colonization of suckling piglets, but
only 8.4% in weaned pigs and 3.9% in grower-ﬁnisher pigs
[38]. This age effect needs to be considered, as the main risk
in terms of foodborne disease is shedding from animals
around the time of slaughter, not when they are neonates,
so speciﬁc details about sample population must be consid-
ered when evaluating different studies. Because of the appar-
ent effect of age on prevalence, studies of animals close to
the time of slaughter would be most appropriate for assess-
ment of foodborne risks, as opposed to studies of other age
groups. Nevertheless, despite these limitations, it is clear
that C. difﬁcile can be found in food animals in some coun-
tries, and it is therefore reasonable to assume that similar
results would be found in many, if not all, other countries.
Characterization of C. difﬁcile strains found in food animals
has given further support to concerns about the potential
for foodborne transmission, particularly the common ﬁnding
of ribotype 078/toxinotype V and isolation of ribotype 027/
NAP1/toxinotype III or related strains (Table 1). Although
the limitations discussed above regarding assessment of prev-
alence should also apply to distribution of strains, some
trends are apparent, particularly the high frequency of isola-
tion of ribotype 078/toxinotype V from different food ani-
mals. However, it should be noted that, despite frequent
referral to ribotype 078/toxinotype V as a ‘food animal
strain’, it is not the only strain found in food animals, and
nor is it the most common in all studies. Current data
strongly suggest that this strain is over-represented in food
animals, but, again, the small number of studies and variability
in results indicate that caution should be exercised when
making broad statements about strain origin. Reports of ribo-
type 027 in food animals have raised signiﬁcant concerns
because of the importance of this strain in human disease,
including large outbreaks.
The original source of C. difﬁcile in food animals is
unknown. Finding the same strains of C. difﬁcile in food ani-
mals and humans strongly suggests that either one was the
source of infection of the other, or that some other com-
mon source resulted in infection of both populations, as con-
vergent evolution of the same strains in people and food
animals would probably be less likely. A study of human and
food animal isolates of ribotype 078 using highly discrimina-
tory methods such as multilocus variable-number tandem
repeat analysis has revealed indistinguishable isolates from
pigs and humans [41], providing further support for the likeli-
hood of interspecies transmission, but no inference as to the
original source.
C. difﬁcile in Retail Meat
The ﬁrst report of C. difﬁcile in retail meat was a rather vague
report, describing the isolation of C. difﬁcile from spoiled vac-
uum-packed meat samples [42], which received little attention.
A study ﬁnding C. difﬁcile in raw meat diets intended for dogs
[43] received similarly little attention, despite the fact that, in
hindsight, these two studies indicated that it was likely that
C. difﬁcile would be found in retail meat. The ﬁrst speciﬁc
investigation of C. difﬁcile contamination of retail meat
intended for human consumption was a study from Canada in
2007 [44]. That study involved a convenience sample of
ground beef (n = 53) and veal (n = 7) from ﬁve stores in two
Canadian provinces. By enrichment culture, C. difﬁcile was iso-
lated from 12 of 60 (20%) samples (21% ground beef and 14%
ground veal). The most common strain, accounting for 67% of
isolates, was a toxigenic strain that possessed genes encoding
TcdA, TcdB and CDT, belonged to toxinotype III, and had an
18-bp deletion in the tcdC gene. This strain was classiﬁed as
NAP1 by PFGE but, although it was similar to ribotype 027 in
all other respects, it had a different ribotype pattern. The
other two toxigenic ribotypes were types previously identiﬁed
in humans in Canada.
A similar study from the USA, using convenience sampling
from stores in the Tuscon, Arizona area, reported isolation
of C. difﬁcile from 37 of 88 (42%) samples, including ground
beef (13/26, 50%), summer sausage (1/7, 14%), ground pork
(3/7, 43%), braunschweiger (10/16, 63%), chorizo (3/10,
30%), pork sausage (3/13, 23%) and ground turkey (4/9, 44%)
[23]. Ribotype 078 was the most common strain, accounting
for 73% of isolates, with the remaining isolates belonging to
ribotype 027. A subsequent Canadian study was performed
with a systematic sampling method to obtain retail meat
samples from three provinces over an 8-month period [45].
The use of systematic national sampling instead of geographi-
cally focal convenience sampling is likely to provide a better
estimate of true population prevalence. C. difﬁcile was iso-
lated from ten of 149 (6.7%) of ground beef samples and
three of 65 (4.6%) of veal chop samples, giving a combined
prevalence of 6.1%. This study used three different culture
techniques, and the prevalence of recovery obtained using
the different methods ranged from 1.4% to 2.3%, with poor
agreement among methods. No methods were identiﬁed as
being superior to others, and it was hypothesized that the
inter-assay variability could have been related to low levels
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of non-homogenously distributed spores in samples. Isolation
of C. difﬁcile was more common in February than in the
other months, although the reason for this apparent season-
ality was unclear. Seventy-seven per cent of isolates were
toxigenic, and all of these had been previously recovered
from humans in Ontario [16]. Two NAP1/toxinotype III
strains that were different from ribotype 027 accounted for
31% of toxigenic isolates, ribotype 077/NAP2 accounted for
23%, and ribotype 014/NAP4 accounted for 15%. A later
study of pork in Canada, using systematic sampling, reported
isolation of C. difﬁcile from only 1.8% of ground pork and
pork chops [46].
The most common strain was ribotype 027/NAP1, which
accounted for 43% of isolates. Interestingly, ribotype 078
was not identiﬁed in any of the ﬁrst three Canadian studies.
Fifteen per cent (25/162) of the chicken meat samples
yielded C. difﬁcile in another Canadian study involving
sampling from four provinces [47].
As opposed to what was found earlier studies, 96% of
isolates were ribotype 078, and the remaining isolate was a
toxinotype 0/NAP4 strain that had been previously found in
humans. In contrast to earlier studies, a more recent Cana-
dian study identiﬁed ribotype 078 as the predominant strain
in beef (86%) and pork (71%) [48].
The reasons for the apparent changes in strain distribution
among the Canadian studies are unclear. Considering that
sampling for most studies involved a national surveillance
programme, sampling bias is less likely, and it is possible that
these changes could have reﬂected a dynamic event of ribo-
type 078 emergence in food animals in Canada; however,
this cannot be proven.
In contrast to the above studies, C. difﬁcile was not iso-
lated from any of 51 beef, 27 pork and six chicken samples
in Austria [49]. As with studies of food animals, care should
be taken in comparing different studies of retail meat. The
use of different sampling and culture methods precludes
objective comparison of prevalence. However, it remains
noteworthy that C. difﬁcile can be found relatively commonly
in various meat products from different regions, and that
strains found in retail meat are usually strains that are also
found in humans. Standardization of sampling, culturing and
identiﬁcation methods would therefore be highly welcome.
A limitation of the initial studies was their reliance on
enrichment methods. While appearing logical, based on the
desire to have optimal recovery in order to estimate the
prevalence of contamination, enrichment culture results in
incomplete information, particularly with respect to the
amount of C. difﬁcile that is present. The infective dose of
C. difﬁcile for humans is not known, and it probably varies
among individuals, but an understanding of the degree of
contamination is critical for assessment of risk. Quantiﬁca-
tion of contamination has only been reported in one study.
That study evaluated beef and pork from four Canadian
provinces, using enrichment and quantitative methods [48].
The enrichment method was shown to have a sensitivity
of £10 spores/g, a conﬁrmation that enrichment methods
can indeed reveal a very low level of contamination.
Whereas C. difﬁcile was isolated from 12% of both beef and
pork samples, 71% of the positive samples were positive only
when enrichment culture was used. Of the samples for
which quantiﬁcation was possible, contamination ranged from
20 to 60 spores/g in pork and from 20 to 240 spores/g in
beef. This suggests that, although contamination may be rela-
tively common, spore numbers tend to be low. Interestingly,
that study also found a small percentage of samples that
were positive using quantitative culture but not enrichment
culture, which could indicate non-homogeneous distribution
of spores in meat.
On the basis of these preliminary studies, there appears
to be a discrepancy between the strain distribution of C. difﬁ-
cile in meat and that in food animals (Table 1). Speciﬁcally,
the prevalence of ribotype 027/NAP1 appears to be dispro-
portionate in food as compared with food animals. It is pos-
sible that this is simply a function of the small number and
scope of current studies, and that broader studies will reveal
a clearer link between food animals and food strains. How-
ever, it is also possible that the strain distribution in faeces
of food animals is not the only factor determining the strain
distribution in food. Although the gastrointestinal tract is
presumably an important source of C. difﬁcile contamination,
other sources must also be considered. These include the
animals’ hides, the slaughterhouse environment, the process-
ing facility environment, processing equipment, the hands of
personnel manipulating meat, and any other environment
where meat is handled or processed prior to sale (e.g.
butcher’s counter in a grocery store). C. difﬁcile spores are
highly resistant to most disinfectants, and therefore could
survive common cleaning and disinfection practices, and per-
sist or accumulate in the environment. Ribotype 027/NAP1
may be particularly adept at persisting in the hospital
environment, because of its high sporulation rate [50]. It is
plausible, although completely hypothetical at this point, that
the high sporulation rate of ribotype 027 could also be an
important component of environmental persistence in
slaughterhouses and meat-processing environments. Better
environmental persistence could result in over-representa-
tion of this strain in meat. Therefore, studies of C. difﬁcile
contamination of slaughterhouse and processing facilities are
required, as are longitudinal studies of the entire process
from ‘farm to fork’, to determine all stages at which
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contamination can occur, and their relative importance.
Importantly, this should lead to identiﬁcation of critical
points where interventions could be applied, if necessary.
Another potential source of infection that requires investi-
gation is the presence of C. difﬁcile spores in healthy muscle
tissue in living animals. A study of healthy equine muscle
found clostridial spores in 19% of samples; however, none
were C. difﬁcile [51]. A pilot study of bovine muscle found
similar rates of clostridial spores in healthy muscle, including
isolation of C. difﬁcile spores from one cow (J. S. Weese,
unpublished data). The origin of spores in healthy muscle has
not been investigated, but it is possible that transient bacter-
aemia, secondary to enteritis at some point in life, may dis-
seminate clostridia to healthy muscle tissue. In this aerobic
environment, clostridial spores would remain dormant. Their
subsequent contribution to contamination of meat remains
unknown but cannot be dismissed, even though levels
of C. difﬁcile spores in healthy muscle would presumably be
very low.
C. difﬁcile in Other Food Products
Although contamination of retail meat has received the most
attention, contamination of other food products may be
equally important, particularly for those that are eaten after
little cleaning or cooking. Minimal investigation of other food
products has been reported. A large study of C. difﬁcile in
South Wales reported isolation of C. difﬁcile from seven of
300 (2.3%) vegetables: two potatoes, one onion, one mush-
room, one carrot, one radish, and one cucumber [52]. The
prevalence of isolation among the different vegetable types
was not reported. A recent Scottish study described isola-
tion of C. difﬁcile from three of 40 (7.5%) ready-to-eat salads
[53].
There is correspondingly little information about the types
of C. difﬁcile found in other food products. Although 71% of
isolates from vegetables from South Wales were toxigenic
[52], typing was not reported. All three isolates from the
Scottish ready-to-eat salads were toxigenic, with two isolates
being classiﬁed as ribotype 017 and one as ribotype 001
[53]. Both are important in human disease, with ribotype 001
being the most common ribotype isolated in hospitals in
Scotland [54].
There are various possible sources of vegetable contami-
nation, all of which are likely to be ultimately human or ani-
mal, such as soil, fertilizer (manure), water, processing
environments, and human hands. The relative impacts of
these are completely unclear.
Heat Tolerance
Clostridial spores are tolerant of adverse environmental con-
ditions, including heat. Persistence of viable C. difﬁcile spores
has been demonstrated even after 120 min at 71C, the rec-
ommended internal temperature for cooking ground meat
[44]. As cooking foods at recommended temperatures can-
not be relied on to kill C. difﬁcile (in contrast to enteropath-
ogens such as Salmonella, Campylobacter and Escherichia coli),
methods for the prevention of even low-level contamination
will be required should C. difﬁcile be proven to be a food-
borne pathogen.
Evidence for Foodborne CDI
There is currently no objective evidence indicating that C. dif-
ﬁcile is a foodborne pathogen. However, one must consider
that few, if any, studies have made concerted (or any) efforts
to investigate this area. Some studies of CA CDI are cur-
rently assessing food exposure as a risk factor; however, it
may be difﬁcult to determine whether food is indeed a
source of infection. One reason for this is the lack of infor-
mation regarding the pathophysiology of foodborne CDI,
should it occur. If, as with most enteropathogens, ingestion
of food contaminated with an infectious dose leads shortly
thereafter to signs of enteric disease, epidemiological studies
of food exposure in CA diarrhoea may be successful in
revealing an association. However, if foodborne exposure is
only of concern for selected, at-risk populations, an associa-
tion may be more difﬁcult to identify, particularly if these at-
risk populations are not adequately deﬁned and those risk
factors queried. Additionally, it is plausible that C. difﬁcile
ingestion could lead to colonization, with subsequent devel-
opment of CDI at a later date, particularly if and when spe-
ciﬁc risk factors are encountered. This potentially indirect or
delayed onset of disease could certainly hamper objective
determination of foodborne risks; identiﬁcation of the role
of food in disease would be very difﬁcult if the point of
exposure may have been days, weeks or months in the past.
It is also possible that colonization due to foodborne patho-
gens could result in transmission to close contacts, either
directly or through environmental contamination, and result
in subsequent colonization or disease; in this scenario, the
food source would not cause disease in the person ingesting
it, but could ultimately result in CDI in another individual.
This may seem unlikely and would be uncommon, but cannot
be dismissed, as it would certainly complicate determination
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of the role of food in CDI. In conclusion, although studies
investigating the role of food in CDI are certainly warranted,
deﬁnitive determination of the role of food in CDI may be
very difﬁcult.
Putting it in Context
On the basis of recent studies of retail meat, it appears that
exposure to low levels of C. difﬁcile is probably a very
common event. As CA CDI is not equally common, there is
clearly not an obligate association between ingestion of C. dif-
ﬁcile and development of disease. The complexity of this
issue should not be overlooked, and there are probably no
simple ways of addressing the question of whether C. difﬁcile
is a foodborne pathogen. There are major knowledge gaps in
our understanding of C. difﬁcile and CDI. Current studies,
while providing critical preliminary information, have limita-
tions and cannot lead to a secure assessment of the role of
C. difﬁcile in foodborne disease. Furthermore, consideration
of CA CDI must involve more than investigations of meat
contamination. Various studies have found that C. difﬁcile can
be isolated from vegetables [52,53], water [52], the house-
hold environment [55], pets [56–58], and healthy humans
[59,60]. All of these sources may be as important as meat. It
is possible that exposure to C. difﬁcile is a regular, if not
daily, occurrence, and that food is only one of many possible
sources. Studies of CA CDI must therefore take a broad,
‘ecological’ approach that takes into account all possible
sources of exposure.
Future directions
Investigation of the potential foodborne risks concerning
CDI is very much in its infancy, and broad areas need to be
addressed. Some of the important questions that need to be
answered are as follows:
1 What role does C. difﬁcile play in CA diarrhoea?
2 Are there food ingestion or contact risk factors for CDI?
Do these apply to all individuals or just selected, high-risk
individuals?
3 How does C. difﬁcile get into food? Is the source the ani-
mal, slaughterhouse environment, processing environ-
ments, hands of personnel at any level, or all of the
above?
4 What is the dose of C. difﬁcile required to cause disease in
healthy and high-risk individuals, and how does that relate
to the levels of C. difﬁcile found in food?
Conclusion
Is C. difﬁcile a serious foodborne threat or an innocent
bystander? The answer is currently completely unclear. An
evidence-based assessment cannot be performed, given the
paucity of data in many areas. There is enough circumstantial
evidence to suggest that C. difﬁcile could cause a foodborne
disease; more careful investigation is required. At the
moment, no one can predict with any degree of certainty
whether foodborne C. difﬁcile will be identiﬁed as an impor-
tant cause of disease, will be completely irrelevant, or will be
of concern only to a select group of high-risk individuals.
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